Thrombotic thrombocytopenic purpura: Description and analysis of 23 cases treated in Chile between 2017 and 2022
Introduction Since the first description of Thrombotic Thrombocytopenic Purpura, caused by a severe deficiency of ADAMTS13, plasma exchange and immunosuppression have become standard treatments, allowing to decrease its high mortality rate. Prospective records of Thrombotic Thrombocytopenic Purpura...
Gardado en:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Medwave Estudios Limitada
2025-07-01
|
| Series: | Medwave |
| Assuntos: | |
| Acceso en liña: | https://www.medwave.cl/investigacion/estudios/3002.html |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|